MedTrace Logo

Study of Vitamin D and Effect on Heart Disease and Insulin Resistance

NCT01093417 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2016-07-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate how Vitamin D affects endothelial function, inflammation, lipids, insulin resistance, vitamin D levels, and parathyroid hormone (PTH).

Conditions

  • Human Immunodeficiency Virus (HIV)
  • Vitamin D Deficiency
  • HIV Infections

Interventions

DRUG

Vitamin D

Vitamin D 4000 IU will be administered to enrollees on the active comparator arm

OTHER

Placebo

Placebo pills will be administered to enrollees in this arm

Sponsors & Collaborators

  • University Hospitals Cleveland Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01093417 on ClinicalTrials.gov